{
  "0": {
    "filled_form": {
      "hardware_4": "hiseq x ten",
      "organism_part_5": "spleen",
      "experimental_designs_10": "time series design",
      "assay_by_molecule_14": "dna assay",
      "study_type_18": "transcription profiling by array"
    },
    "context": {
      "hardware_4": "RegionsNATURECOMMUNICATIONSTableMultivariateLASSOanalysis.ItemAlltreatmentsPLAT/PYRTarget-monoTOP/PYRPriorTreatmentGendernrofTandemDuplicationsnrof10kb\u20131MbdeletionsDBS2DBS5DBS11SBS17bSBS39SBS41APCKRASPIK3CAFBXW7GainGainGainGainGainGainGainGainGainLossLossLossLossLossLossLossLossLossLoss(nogenesinpeak)(nogenesinpeak)OxaliplatincontainingItemsthatreachedunivariatestatisticalsigni\ufb01cance(pwereusedinamultivariablepenalized",
      "organism_part_5": "beconsideredasacontra-indicationfortheuseofanti-EGFRtreatment.Molecularbiomarkersforpotentialoff-labelusethatwerefoundinourcohortincludeampli\ufb01cationsofERBB2METandlossofBRCA1andBRCA2throughdeletionorhighimpactlossofTSC1andTSC2throughhighimpactandpossiblefusionsofInpatientsinourcohortcarriedaKRASG12Cforwhichaninhibitormaybecomeavailableinthenearfuture33.Inforofourpatientsoneormoretargetedtreatmentsarepotentially",
      "experimental_designs_10": "clinicalcontributors.andaremembersoftheCPCT-02studyteamand/orCPCTboard.coordinatedthesequencingofsamplesandcontributedtothebioinformaticsanalyses.CompetinginterestsTheauthorsdeclarenocompetinginterests.AdditionalinformationinformationisavailableforthispaperatPeerreviewinformationNatureCommunicationsthanksKinSilviaMarsoniandthereviewer(s)fortheircontributiontothepeerreviewofthiswork.Peerreviewerreportsareavailable.",
      "assay_by_molecule_14": "beconsideredasacontra-indicationfortheuseofanti-EGFRtreatment.Molecularbiomarkersforpotentialoff-labelusethatwerefoundinourcohortincludeampli\ufb01cationsofERBB2METandlossofBRCA1andBRCA2throughdeletionorhighimpactlossofTSC1andTSC2throughhighimpactandpossiblefusionsofInpatientsinourcohortcarriedaKRASG12Cforwhichaninhibitormaybecomeavailableinthenearfuture33.Inforofourpatientsoneormoretargetedtreatmentsarepotentially",
      "study_type_18": "clinicalcontributors.andaremembersoftheCPCT-02studyteamand/orCPCTboard.coordinatedthesequencingofsamplesandcontributedtothebioinformaticsanalyses.CompetinginterestsTheauthorsdeclarenocompetinginterests.AdditionalinformationinformationisavailableforthispaperatPeerreviewinformationNatureCommunicationsthanksKinSilviaMarsoniandthereviewer(s)fortheircontributiontothepeerreviewofthiswork.Peerreviewerreportsareavailable."
    }
  }
}